Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

View:
Post by subaru1 on Jul 25, 2022 12:44pm

Insider

No insiders are buying even at these low prices ????? for me it means that we aren't ready for a turnaround yet.
Comment by alleyesonme on Jul 25, 2022 5:14pm
They can't.....non disclosure agreements....atleast two....that would be considered insider trading....this is why....
Comment by Solid1 on Jul 26, 2022 4:58am
Jeep I think so too  Article 13 California... Steve Beagle who takes over the marketing in the USA  If insiders were buying in the public market it could be construed as insider trading.... but don't worry the insiders have their options.... 
Comment by subaru1 on Aug 03, 2022 5:05pm
Look at PCLO, the CEO is buying into the market. Look at the chart since he is buying if our CEO would do the same think we would already be at over $0,25. PCLO has revenue of just over 1 million for their first quarter and they have 150 million share on the market.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities